9 Einträge |
Seite 1 / 1
![]() |
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. |
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A |
The Lancet. Oncology. 2017 Nov 13. pii: S1470-2045(17)30717-9. doi: 10.1016/S1470-2045(17)30717-9 |
PMID: 29146401 |
Incidence of Gastric Adenocarcinoma among Lesions Diagnosed as Low-grade Adenoma/Dysplasia on Endoscopic Biopsy: A Multi-center, Prospective, Observational Study. |
Maekawa A, Kato M, Nakamura T, Komori M, Yamada T, Yamamoto K, Ogiyama H, Nakahara M, Kawai N, Yabuta T, Mukai A, Hayashi Y, Nishida T, Iijima H, Tsujii M, Morii E, Takehara T |
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society. 2017 Nov 2. doi: 10.1111/den.12980 |
PMID: 29094455 |
Chronic thromboembolic pulmonary hypertension in Austria and Japan. |
Chausheva S, Naito A, Ogawa A, Seidl V, Winter MP, Sharma S, Sadushi-Kolici R, Campean IA, Taghavi S, Moser B, Klepetko W, Ishida K, Matsubara H, Sakao S, Lang IM |
The Journal of thoracic and cardiovascular surgery. 2019 Jan 21. pii: S0022-5223(19)30071-6. doi: 10.1016/j.jtcvs.2019.01.019 |
PMID: 31084984 |
A diagnostic algorithm of magnifying endoscopy with crystal violet staining for non-ampullary duodenal epithelial tumors. |
Toya Y, Endo M, Oizumi T, Akasaka R, Yanai S, Kawasaki K, Nakamura S, Eizuka M, Fujita Y, Uesugi N, Ishida K, Sugai T, Matsumoto T |
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society. 2020 Jan 29. doi: 10.1111/den.13640 |
PMID: 31997426 |
Artificial T Cell Adaptor Molecule-Transduced TCR-T Cells Demonstrated Improved Proliferation Only When Transduced in a Higher Intensity. |
Sakai T, Terakura S, Miyao K, Okuno S, Adachi Y, Umemura K, Julamanee J, Watanabe K, Hamana H, Kishi H, Leitner J, Steinberger P, Nishida T, Murata M, Kiyoi H |
Molecular therapy oncolytics. 2020 Aug 28. doi: 10.1016/j.omto.2020.08.014. pii: S2372-7705(20)30131-5. pmc: PMC7509457 |
PMID: 33005728 |
Composite CD79A/CD40 costimulatory endodomain enhances CD19CAR-T cell proliferation and survival. |
Julamanee J, Terakura S, Umemura K, Adachi Y, Miyao K, Okuno S, Takagi E, Sakai T, Koyama D, Goto T, Hanajiri R, Hudecek M, Steinberger P, Leitner J, Nishida T, Murata M, Kiyoi H |
Molecular therapy : the journal of the American Society of Gene Therapy. 2021 Apr 30. pii: S1525-0016(21)00252-5. doi: 10.1016/j.ymthe.2021.04.038 |
PMID: 33940156 |
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma. |
Fessas P, Naeem M, Pinter M, Marron TU, Szafron D, Balcar L, Saeed A, Jun T, Dharmapuri S, Gampa A, Wang Y, Khan U, Muzaffar M, Navaid M, Lee PC, Bulumulle A, Yu B, Paul S, Nimkar N, Bettinger D, Hildebrand H, Abugabal YI, Pressiani T, Personeni N, Nishida N, Kudo M, Kaseb A, Huang YH, Ang C, Pillai A, Rimassa L, Naqash AR, Sharon E, Cortellini A, Pinato DJ |
Liver cancer. 2021 Oct 8. doi: 10.1159/000519108. pii: lic-0010-0583. pmc: PMC8647090 |
PMID: 34950181 |
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma. |
Muhammed A, Fulgenzi CAM, Dharmapuri S, Pinter M, Balcar L, Scheiner B, Marron TU, Jun T, Saeed A, Hildebrand H, Muzaffar M, Navaid M, Naqash AR, Gampa A, Ozbek U, Lin JY, Perone Y, Vincenzi B, Silletta M, Pillai A, Wang Y, Khan U, Huang YH, Bettinger D, Abugabal YI, Kaseb A, Pressiani T, Personeni N, Rimassa L, Nishida N, Di Tommaso L, Kudo M, Vogel A, Mauri FA, Cortellini A, Sharma R, D'Alessio A, Ang C, Pinato DJ |
Cancers. 2021 Dec 31. pii: cancers14010186. doi: 10.3390/cancers14010186 |
PMID: 35008350 |
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: a real-world study. |
D'Alessio A, Fulgenzi CAM, Nishida N, Schönlein M, von Felden J, Schulze K, Wege H, Gaillard VE, Saeed A, Wietharn B, Hildebrand H, Wu L, Ang C, Marron TU, Weinmann A, Galle PR, Bettinger D, Bengsch B, Vogel A, Balcar L, Scheiner B, Lee PC, Huang YH, Amara S, Muzaffar M, Naqash AR, Cammarota A, Personeni N, Pressiani T, Sharma R, Pinter M, Cortellini A, Kudo M, Rimassa L, Pinato DJ |
Hepatology (Baltimore, Md.). 2022 Mar 21. doi: 10.1002/hep.32468 |
PMID: 35313048 |
9 Einträge |
Seite 1 / 1
![]() |